{"id":26464,"date":"2020-10-20T15:30:00","date_gmt":"2020-10-20T15:30:00","guid":{"rendered":"https:\/\/ogkologos.com\/esmo-2020-new-treatments-for-advanced-kidney-cancer-prostate-cancer-and-bladder-cancer\/"},"modified":"2024-11-03T15:16:16","modified_gmt":"2024-11-03T15:16:16","slug":"esmo-2020-new-treatments-for-advanced-kidney-cancer-prostate-cancer-and-bladder-cancer","status":"publish","type":"post","link":"https:\/\/ogkologos.com\/en\/esmo-2020-new-treatments-for-advanced-kidney-cancer-prostate-cancer-and-bladder-cancer\/","title":{"rendered":"ESMO 2020: New Treatments for Advanced Kidney Cancer, Prostate Cancer, and Bladder Cancer"},"content":{"rendered":"<div><img decoding=\"async\" src=\"https:\/\/www.cancer.net\/sites\/cancer.net\/files\/2020-esmo-fb.png\" class=\"ff-og-image-inserted\"><\/div>\n<p>The 2020 European Society for Medical Oncology (ESMO) Virtual Congress was held online from September 19 to September 21. In this podcast, Neeraj Agarwal, MD, discusses 3 clinical trials on genitourinary (GU) cancers presented at the meeting and what people with cancer should know about them.<\/p>\n<ul readability=\"4.4832506203474\">\n<li readability=\"3.2246153846154\">\n<p>Results from the phase III <a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03141177\" target=\"_blank\" rel=\"noopener noreferrer\">CheckMate 9ER clinical trial<\/a>, which studied whether a combination of the <a href=\"https:\/\/www.cancer.net\/node\/24376\">angiogenesis inhibitor<\/a> cabozantinib (Cometriq) with the immunotherapy drug nivolumab (Opdivo) improved the quality of life for people with advanced <a href=\"https:\/\/www.cancer.net\/node\/31256\">kidney cancer<\/a>, as well as how long it stopped the cancer from growing. [2:35]<\/p>\n<\/li>\n<li readability=\"1.6497695852535\">\n<p>Findings from the phase III <a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02987543\" target=\"_blank\" rel=\"noopener noreferrer\">PROfound clinical trial<\/a>, which examined whether treating advanced <a href=\"https:\/\/www.cancer.net\/node\/31382\">prostate cancer<\/a> with the targeted therapy olaparib (Lynparza) helped specific patients with a biomarker live longer. [5:16]<\/p>\n<\/li>\n<li readability=\"1.6335877862595\">\n<p>Research from the phase III <a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02603432\" target=\"_blank\" rel=\"noopener noreferrer\">JAVELIN Bladder 100 clinical trial<\/a>, which studied whether treating advanced <a href=\"https:\/\/www.cancer.net\/node\/31330\">bladder cancer<\/a> with the immunotherapy drug avelumab (Bavencio) in people who had already received platinum-based chemotherapy helped them live longer. [11:18]<\/p>\n<\/li>\n<\/ul>\n<p>Dr. Agarwal is a professor of medicine and the director of the Genitourinary Oncology Program at the Huntsman Cancer Institute at the University of Utah in Salt Lake City, Utah. He is also a <a href=\"https:\/\/www.cancer.net\/about-us\/cancernet-editorial-board\/specialty-editors\/neeraj-agarwal-md\" target=\"_blank\" rel=\"noopener noreferrer\">Cancer.Net Specialty Editor for Genitourinary Cancer<\/a>. <a href=\"https:\/\/coi.asco.org\/share\/BSQ-8ERZ\/Neeraj\" target=\"_blank\" rel=\"noopener noreferrer\">View Dr. Agarwal\u2019s disclosure information.<\/a><\/p>\n<p><strong><em>Was this podcast useful?<\/em><\/strong> <em>Please subscribe, rate, and review Cancer.Net Podcasts on Apple Podcasts or Google Play. This prerecorded podcast can be listened to online or downloaded to your computer. A transcript is also available. For more information, visit the<\/em> <a href=\"http:\/\/www.cancer.net\/blog\/podcasts\"><em>Cancer.Net podcast page<\/em><\/a><em><span>.<\/span><\/em><\/p>\n<p><em>Cancer.Net podcasts are edited for length and content.<\/em><\/p>\n<p><a href=\"https:\/\/www.cancer.net\/blog\/2020-10\/esmo-2020-new-treatments-advanced-kidney-cancer-prostate-cancer-and-bladder-cancer\">Source<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The 2020 European Society for Medical Oncology (ESMO) Virtual Congress was held online from September 19 to September 21. In this podcast, Neeraj Agarwal, MD, discusses 3 clinical trials on genitourinary (GU) cancers presented at the meeting and what people with cancer should know about them. Results from the phase III CheckMate 9ER clinical trial, [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[5137],"tags":[],"class_list":["post-26464","post","type-post","status-publish","format-standard","hentry","category-world-news"],"_links":{"self":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts\/26464","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/comments?post=26464"}],"version-history":[{"count":1,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts\/26464\/revisions"}],"predecessor-version":[{"id":44113,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts\/26464\/revisions\/44113"}],"wp:attachment":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/media?parent=26464"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/categories?post=26464"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/tags?post=26464"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}